Covered recipient · General Payments record
SHAMALA MOHANASUNDARAM
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,982.43
- Reported across 109 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $651.01 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $424.05 | 23 |
| PFIZER INC. | $77.11 | 5 |
| GlaxoSmithKline, LLC. | $61.78 | 2 |
| Lilly USA, LLC | $41.11 | 2 |
| MAYNE PHARMA COMMERCIAL LLC | $30.35 | 4 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.50 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051780 | CMS |
| ABBVIE INC. | $21.45 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051782 | CMS |
| ABBVIE INC. | $31.13 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051784 | CMS |
| ABBVIE INC. | $22.35 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051786 | CMS |
| ABBVIE INC. | $22.94 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051788 | CMS |
| ABBVIE INC. | $24.60 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051790 | CMS |
| ABBVIE INC. | $25.22 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051792 | CMS |
| ABBVIE INC. | $22.08 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051794 | CMS |
| ABBVIE INC. | $11.00 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051796 | CMS |
| ABBVIE INC. | $18.74 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051798 | CMS |
| ABBVIE INC. | $30.02 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051800 | CMS |
| ABBVIE INC. | $8.46 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051802 | CMS |
| ABBVIE INC. | $5.06 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051804 | CMS |
| ABBVIE INC. | $5.50 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051806 | CMS |
| ABBVIE INC. | $6.13 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051808 | CMS |
| ABBVIE INC. | $24.59 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051810 | CMS |
| ABBVIE INC. | $25.72 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051812 | CMS |
| ABBVIE INC. | $13.80 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051814 | CMS |
| ABBVIE INC. | $26.25 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051816 | CMS |
| ABBVIE INC. | $17.39 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051818 | CMS |
| ABBVIE INC. | $15.03 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051820 | CMS |
| ABBVIE INC. | $18.14 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051822 | CMS |
| ABBVIE INC. | $11.95 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105051824 | CMS |
| GlaxoSmithKline, LLC. | $31.10 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116612379 | CMS |
| GlaxoSmithKline, LLC. | $30.68 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116192932 | CMS |
| Lilly USA, LLC | $21.69 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135405180 | CMS |
| Lilly USA, LLC | $19.42 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135373498 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $5.70 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154682243 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $5.55 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154682245 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $9.09 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154682247 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $10.01 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154682249 | CMS |
| PFIZER INC. | $14.41 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131140008 | CMS |
| PFIZER INC. | $15.34 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131378558 | CMS |
| PFIZER INC. | $15.86 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131762822 | CMS |
| PFIZER INC. | $16.61 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132103199 | CMS |
| PFIZER INC. | $14.89 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131028880 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.61 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153640550 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.